Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Rhea-AI Summary

Seer (Nasdaq: SEER) has been ranked No. 57 on the 2024 Deloitte Technology Fast 500™, achieving a remarkable 2,440% revenue growth. The company attributes this growth to increased adoption of its Proteograph Product Suite and customer discoveries across neurodegenerative disease, cancer, and metabolic disease. Key achievements include launching a technology access center in Europe, platform usage on the SpaceX Inspiration4 mission, and establishing a co-marketing agreement with Thermo Fisher Scientific. This marks Seer's second consecutive appearance on the list, improving from their No. 5 ranking in 2023.

Positive

• Achieved 2,440% revenue growth over three years
• Secured co-marketing and sales agreement with Thermo Fisher Scientific
• Expanded international presence with European technology access center
• Demonstrated platform adoption in space research (SpaceX Inspiration4)

Negative

• None.

Attributes 2,440% revenue growth to increased adoption of its Proteograph™ Product Suite and exciting discoveries made by Seer customers across multiple areas of biology and disease

REDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it ranked No. 57 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 30th year. Seer grew 2,440% during this period.

Seer’s President and CFO, David Horn, credits increased adoption of Seer’s Proteograph Product Suite, as well as new discoveries made by its customers across neurodegenerative disease, cancer, and metabolic disease, with the company’s 2,440% revenue growth.

"This has been an exciting year for Seer, from the launch of our technology access center in Europe, to seeing our Proteograph platform used by astronauts on the SpaceX Inspiration4 mission, to the recent announcement of our co-marketing and sales agreement with Thermo Fisher Scientific,” Horn said. “We’re proud to see continuing validation of our work providing customers and the broader scientific community with the power to enable deep proteomic insights at a scale and price point that hasn’t been possible before."

Seer previously ranked No. 5 as a Technology Fast 500 award winner for 2023.

Overall, 2024 Technology Fast 500 companies achieved revenue growth ranging from 201% to 153,625% over the three-year time frame, with an average growth rate of 1,981% and median growth rate of 460%.

About the 2024 Deloitte Technology Fast 500:

Now in its 30th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2020 to 2023.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

About Seer:

Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.

Media Contact: Patrick Schmidt pr@seer.bio

Investor Contact: Carrie Mendivil investor@seer.bio

About Deloitte:

Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world’s most admired brands, including nearly 90% of the Fortune 500® and more than 8,500 U.S.-based private companies. At Deloitte, we strive to live our purpose of making an impact that matters by creating trust and confidence in a more equitable society. We leverage our unique blend of business acumen, command of technology, and strategic technology alliances to advise our clients across industries as they build their future. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Bringing more than 175 years of service, our network of member firms spans more than 150 countries and territories. Learn how Deloitte’s approximately 460,000 people worldwide connect for impact at www.deloitte.com.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

FAQ

What was Seer's (SEER) ranking on the 2024 Deloitte Technology Fast 500?

Seer (SEER) ranked No. 57 on the 2024 Deloitte Technology Fast 500™ list.

What was Seer's (SEER) revenue growth percentage in the 2024 Deloitte Technology Fast 500?

Seer (SEER) achieved a revenue growth of 2,440% during the evaluation period.

What major partnership did Seer (SEER) announce in 2024?

Seer (SEER) announced a co-marketing and sales agreement with Thermo Fisher Scientific.

How did Seer's (SEER) 2024 Deloitte ranking compare to 2023?

Seer's ranking changed from No. 5 in 2023 to No. 57 in 2024 on the Deloitte Technology Fast 500™ list.